<DOC>
	<DOCNO>NCT01983605</DOCNO>
	<brief_summary>Evaluate safety effectiveness LARIAT Suture Delivery device exclude leave atrial appendage 100 patient .</brief_summary>
	<brief_title>Left Atrial Appendage Exclusion Study</brief_title>
	<detailed_description>The objective study evaluate safety effectiveness SentreHEART suture delivery system exclusion leave atrial appendage 100 treated patient .</detailed_description>
	<criteria>1 . Subject great equal 18 year age 2 . Subject atrial fibrillation ( paroxysmal persistent ) 3 . Subject poor candidate Warfarin ( contraindicate , labile INR , noncompliant ) 4 . Subject willing able provide write informed consent 5 . Subject life expectancy least 1 year 6 . Subject willing able return schedule follow visit 1 . Previous cardiac surgery 2 . Thrombus leave atrial appendage leave atrium 3 . NYHA Class IV heart failure symptoms 4 . Need emergent cardiac surgery ( i.e . cardiogenic shock ) 5 . LAA appropriate exclusion base upon intraoperative evaluation 6 . Current diagnosis active systemic infection 7 . Renal failure require dialysis hepatic failure 8 . A known drug and/or alcohol addiction 9 . Mental impairment condition , may allow subject understand nature , significance scope study 10 . Pregnancy desire get pregnant within 12 month study treatment 11 . Preoperative need intraaortic balloon pump intravenous inotropes 12 . Patients treat thoracic radiation 13 . Patients current chemotherapy 14 . Patients longterm treatment steroid include intermittent use inhale steroid respiratory disease . 15 . Patients know connective tissue disorder , i.e . Lupus 16 . Previous history pericarditis 17 . Presence PFO/ASD valve implant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>